pyrroles has been researched along with thioacetamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aeed, H; Bruck, R; Gavish, D; Sharvit, E; Shirin, H | 1 |
| El-Awady, MS; Makled, MN; Sharawy, MH | 1 |
| Al-Gayyar, MMH; Alattar, A; Alshaman, R; El-Kannishy, SMH; Hamdan, AM; Hassan, HM | 1 |
3 other study(ies) available for pyrroles and thioacetamide
| Article | Year |
|---|---|
Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
Topics: Animals; Atorvastatin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fluorobenzenes; Hepatic Stellate Cells; Heptanoic Acids; Hypertension, Portal; In Vitro Techniques; Incidence; Injections; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Oxidative Stress; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Thioacetamide | 2013 |
The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptin.
Topics: Actins; Animals; Becaplermin; Leptin; Liver; Liver Cirrhosis; Male; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles; Rats, Sprague-Dawley; Thioacetamide; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2019 |
Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; beta Catenin; Cell Movement; Cytokines; Fibroblast Growth Factor 2; Fibrosis; Inflammation Mediators; Liver Neoplasms, Experimental; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyridines; Pyrroles; Rats, Sprague-Dawley; Thiazolidinediones; Thioacetamide; Transforming Growth Factor beta1; Wnt Signaling Pathway | 2021 |